Search | Aplastic Anemia and MDS International Foundation


Search results

  1. A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes

    ... Use of darbepoetin alfa to treat anemia in patients with lower-risk ...

    Research Article last updated 07/11/2017 - 10:16am.

  2. Variations in erythropoiesis-stimulating agent administration in transfusion-dependent myelodysplastic syndromes impact response

    ... the association of timing of ESA initiation, agent (epoetin alfa, darbepoetin) and number of weeks of ESA use with response in MDS patients in ...

    Research Article last updated 07/20/2018 - 5:15pm.

  3. Darbepoetin Alfa

    ... called erythropoiesis-stimulating agents (ESAs). Darbepoetin alfa can help improve red blood cell counts in bone marrow ...

    Drug last updated 03/24/2016 - 12:32pm.

  4. PNH Drug Information

    ... Generic Name Brand Name darbepoetin alfa A ranesp ...

    Page last updated 01/20/2015 - 4:56pm.

  5. Drugs

    ... Z enapax darbepoetin alfa A ranesp epoetin ...

    Page last updated 03/02/2016 - 9:11am.

  6. MDS Drug Information

    ... N eoral, S andimmune darbepoetin alfa A ranesp ...

    Page last updated 01/20/2015 - 4:46pm.

  7. My MDS Diagnosis and Progression of Treatment

    ... In August, it was decided to try weekly injections of darbepoetin alfa (Aranesp®) (200mcg) to try to stimulate my marrow to produce more red ...

    Patient Chronicle last updated 12/15/2016 - 11:19am.